The Role of Targeted Therapy in Severe Asthma with Type 2 Inflammation

 
Share
 

Manage episode 272403817 series 2606426
By ReachMD. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Host: Sandra G. Adams, MD, MS, FCCP
Guest: Mario Castro, MD, MPH
There's been an emergence of novel therapies for the treatment of severe asthma, including biologics targeting inflammatory pathways. These therapeutic options have ushered in a new era of personalized asthma management, which is why clinicians must be able to identify which patients are most likely to respond to newer biologic agents and need to be knowledgeable of the biologic and physiologic markers that form the basis for selecting a treatment.

25 episodes